1. An apparatus comprising:
a plurality of microphones coupled to receive a bias current in series.
2. The apparatus as recited in claim 1 further comprising an integrated circuit including a current source to supply a bias current to a first one of the microphones and wherein a second one of the microphones is coupled to receive the bias current from the first one of the microphones.
3. The apparatus as recited in claim 1 wherein the integrated circuit includes a plurality of inputoutput terminals, each of the inputoutput terminals coupled to a respective two microphones of the plurality of microphones.
4. The apparatus as recited in claim 1,
wherein the integrated circuit includes a plurality of amplifiers coupled to the microphones, and
wherein the amplifiers are differential, each of the amplifiers having a first input coupled to an input node of a respective one of the microphones and a second input coupled to an output node of the respective one of the microphones.
5. The apparatus as recited in claim 1 wherein the microphones are electret condenser microphones (ECMs) or microelectromechanical (MEMS) microphones.
6. The apparatus as recited in claim 1 wherein the current source is programmable to supply a variable amount of current as the bias current according to a control setting.
7. The apparatus as recited in claim 6 wherein the control setting for the current source is adjusted to adjust the bias current according to a detected level of voice activity.
8. An apparatus comprising:
a plurality of microphones configurable to be coupled in series;
a current source coupled to supply a bias current to an input of a configurable one of the microphones; and
a ground node coupled to an output of one of the microphones.
9. The apparatus as recited in claim 8 further comprising:
a plurality of switches configurable to cause two or more of the microphones to be coupled in series with one of the microphones connected to receive the bias current from the current source and another of the microphones being connected to ground to provide a path for the bias current to flow through the microphones.
10. The apparatus as recited in claim 8,
wherein one or more of the plurality of microphones may be bypassed according to configuration of the switches.
11. A method of operating a plurality of microphones comprising:
providing a bias current to a first input node of a first microphone; and
providing the bias current to a second input node of a second microphone that is serially connected to an output node of the first microphone to receive the bias current.
12. The method as recited in claim 11 further comprising:
supplying a first voltage on an input node of the first microphone to a first input of a first differential amplifier and supplying a second voltage on an output node of the first microphone to a second input of the first differential amplifier; and
supplying the second voltage on an input node of the second one of the microphones to a first input of a second differential amplifier and supplying a third voltage on an output node of the second microphone to a second input of the second differential amplifier.
13. The method as recited in claim 11 further comprising varying the bias current according to a control setting of the bias current generator.
14. The method as recited in claim 13 further comprising varying the bias current according to a detected level of voice activity.
15. The method as recited in claim 11 further comprising:
configuring a plurality of switches such that the first and second ones of the microphones are in series.
16. The method as recited in claim 15 further comprising:
reconfiguring the plurality of switches to cause a third microphone to be in series with the first and second microphones.
17. The method as recited in claim 16 further comprising reconfiguring the switches to remove one of the first, second, and third microphones from being in series.
18. The method as recited in claim 11 further comprising changing a number of microphones coupled in series to receive the bias current and adjusting an amount of the bias current.
19. The method as recited in claim 11 further comprising suppressing circuit distortions in microphone output caused by serial connecting the bias current using digital signal processing.
20. An apparatus comprising:
a current source;
a plurality of switches to supply one of a plurality of inputoutput terminals with a bias current from the current source according to configuration of the switches; and
a plurality of amplifiers coupled to the plurality of terminals to amplify respective voltages present on the inputoutput terminals.
21. The apparatus as recited in claim 20 further comprising:
a plurality of microphones coupled to the inputoutput terminals and coupled in series so that the bias current flows through the plurality of microphones.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A method for measuring protein kinase activity, said method comprising:
(a) providing a first solution comprising ATP and a protein kinase to be tested, and a second solution comprising ATP in the absence of said kinase to be tested;
(b) adding a substrate capable of being phosphorylated by the protein kinase to be tested to the first and second solutions of step (a);
(c) measuring the concentration of ATP andor ADP, or the rate of change thereof with respect to time, in each of the reaction mixtures formed in step (b) using a bioluminescence reaction; and
(d) using information about the concentration of ATP andor ADP to determine the activity of the protein kinase to be tested.
2. A method for identifying a compound which modulates the activity of a protein kinase, said method comprising:
(a) providing a first solution comprising ATP, a protein kinase and a compound to be tested, and a second solution comprising ATP and the protein kinase in the absence of said compound to be tested;
(b) adding a substrate capable of being phosphorylated by the protein kinase to the first and second solutions of step (a);
(c) measuring the concentration of ATP andor ADP, or the rate of change thereof with respect to time, in each of the reaction mixtures formed in step (b) using a bioluminescence reaction;
(d) using information about the concentration of ATP andor ADP to determine the activity of the protein kinase is the first and second solutions;
(e) comparing the activity of the protein kinase in the first solution with the activity of the protein kinase in the second solution to identify compounds which modulate a protein kinase, whereby the compound to be tested is identified as a protein kinase modulator if the activity of the protein kinase in the first solution is different from the activity of the protein kinase in the second solution.
3. The method of claim 1 wherein the first and second solutions of step (a) are substantially cell-free.
4. The method of claim 2 wherein the first and second solutions of step (a) are substantially cell-free.
5. The method of claim 2 or 4 wherein the compound to be tested is identified as a protein kinase inhibitor if the activity of the kinase in the first solution is lower than the activity of the kinase in the second solution.
6. The method of claim 5 wherein the compound to be tested is identified as a protein kinase inhibitor if the activity of the kinase in the first solution is less than 50% of the activity of the kinase in the second solution.
7. The method of claim 2 or 4 wherein the compound to be tested is identified as a protein kinase activator if the activity of the kinase in the first solution is higher than the activity of the kinase in the second solution.
8. The method of claim 7 wherein the compound to be tested is identified as a protein kinase activator if the activity of the kinase in the first solution is at least 50% greater than the activity of the kinase in the second solution.
9. The method of claim 2 further comprising repeating steps (a) to (d) one or more times using a different kinase and its corresponding substrate each time.
10. The method of claim 1 or 2 wherein the kinase is activated prior to step (a).
11. The method of claim 1 or 2 wherein the first and second solutions of step (a) comprise a buffer.
12. The method of claim 11 wherein the buffer is Hepes buffer.
13. The method of claim 1 or 2 wherein steps (a) to (c) are carried out consecutively.
14. The method of claim 13 wherein following addition of the substrate in step (b), the reaction mixture is allowed to react for 1 hour at room temperature prior to step (c).
15. The method of claim 13 comprising a further step (b), carried out after step (b) and before step (c), of adding a reagent to the reaction mixture formed in step (b) which stops the reaction of the kinase with the substrate.
16. The method of claim 15 wherein the stopping reagent is selected from the group consisting of phosphoric acid, EGTA and EDTA.
17. The method of claim 15 comprising a further step (b), carried out after step (b) and before step (c), of adjusting the pH of the mixture formed in step (b) to pH 7.0.
18. The method of claim 17 wherein step (b) comprises adding Hepes buffer.
19. The method of claim 1 or 2 wherein steps (b) and (c) are carried out simultaneously.
20. The method of claim 1 or 2 wherein step (c) comprises:
(i) adding a bioluminescent reagent comprising luciferin or a derivative thereof and a luciferase to said reaction mixtures, said luciferin or a derivative thereof emitting light in a bioluminescent reaction with the luciferase in the presence of ATP; and
(ii) measuring the intensity of light emitted by the resultant bioluminescent reaction, or its change with respect to time, as a measure of ATP concentration.
21. The method of claim 20 wherein step (c) further comprises the following steps carried out after the light intensity measured in step (ii) has reached a substantially constant level:
(iii) adding a reagent that converts ADP to ATP;
(iv) adding a bioluminescent reagent comprising luciferin or a derivative thereof and luciferase to said reaction mixture of step (iii); and
(v) measuring the intensity of light emitted by the resultant bioluminescent reaction
wherein the difference in the intensity of light in step (v) and the steady state intensity of light in step (ii) is a measure of ADP concentration in the reaction mixture of step (ii).
22. The method of claim 2 wherein the kinase is JNK-1 and the substrate is GST-c-jun.
23. The method of-Claim 2 wherein the kinase is MAP Kinase-1 (ERK-1) and the substrate is myelin basic protein.
24. The method of claim 2 wherein the kinase is MAP Kinase-2 (ERK-2) and the substrate is myelin basic protein.
25. The method of claim 2 wherein the kinase is PKA and the substrate is Kemptide.
26. The method of claim 2 wherein the kinase is JNK-2 and the substrate is GST-c-jun.
27. The method of claim 2 wherein the kinase is MEK-1 and the substrate is inactive MAP Kinase-2 (ERK-2).
28. The method of claim 2 wherein the kinase is JNK22 and the substrate is ATF-2.
29. The method of claim 2 wherein the kinase is JNK22 and the substrate is c-jun.
30. The method of claim 2 wherein the kinase is SAPK-3 and the substrate is myelin basic protein.
31. The method of claim 2 wherein the kinase is SAPK-4 and the substrate is myelin basic protein.
32. The method of claim 2 wherein the kinase is raf-1 and the substrate is inactive MEK-1.
33. A compound identified using a method according to claim 2.
34. A kit for use in the method of claim 2 comprising:
(a) a bioluminescent reagent comprising luciferin or a derivative thereof and a luciferase, said luciferin or a derivative thereof emitting light in a bioluminescent reaction with the luciferase in the presence of ATP;
(b) a kinase;
(c) a substrate capable of being phosphorylated by said kinase; and
(d) ATP.
35. The kit of claim 34 further comprising one or more buffers for reconstituting, diluting or dissolving the bioluminescent reagent, kinase, substrate andor ATP.
36. The kit of claim 34 further comprising a reagent capable of stopping the reaction of said kinase with said substrate.
37. The kit of claim 34 further comprising one or more reagent(s) which converts ADP to ATP.
38. The kit of claim 37, wherein the reagent which converts ADP to ATP comprises pyruvate kinase and phosphoenol pyruvate.
39. The kit of claim 34 further comprising two or more different kinases and their substrates.
40. The kit of claim 34 wherein the reagent or reagents is or are provided in lyophilised form.
41. The kit of claim 34 further comprising a multiwell microtitre plate.
42. The kit of claim 41 wherein the multiwell microtitre plate contains 96 wells or more.